2016 Symposium Moderators
Alberto Bazzocchi, MD, PhD
Dr. Bazzocchi works as a consultant radiologist at the Rizzoli Orthopaedic Institute's department of Diagnostic and Interventional Radiology. His team's clinical and research activity covers a wide range of topics, and he is personally the principal investigator for several clinical trials investigating the use of focused ultrasound in musculoskeletal diseases, including bone tumors and osteoarthritis.
David Brenin, MD
Dr. Brenin is the Chief of Breast Surgery and the Co-Director of the University of Virginia Cancer Program's Breast Center. He is the Principal Investigator of a study evaluating ultrasound-guided focused ultrasound ablation of breast fibroadenoma.
Tim Bullock, PhD
Dr. Bullock received his PhD in Immunology from Thomas Jefferson University in 1996 and postdoctoral training at the University of Virginia (UVA) as a fellow of the Cancer Research Institute. In 2003, he was recruited into a tenure-track position with the Human Immune Therapy Center and Department of Pathology at UVA, where he received Young Investigator/Scholar awards from the Cancer Research Institute; the Dana Foundation; the Sidney Kimmel Foundation and the Melanoma Research Alliance. He is now a tenured Associate Professor at UVA. Dr. Bullock has published 25 articles pertaining to immune responses and their manipulation in the context of cancer. His lab continues to pursue aspects of basic and translational immunology that impact on the capacity of immune responses to control tumor outgrowth, with a special emphasis on the regulation of immune cell function within tumors and how to integrate conventional and novel therapies, such as focused ultrasound, with immunotherapy.
Alexandre C. Carpentier, M.D., Ph.D.
Pr. Carpentier. is a neurosurgeon specialized in brain tumor and epilepsy surgery at the Pitié-Salpêtrière university hospital, Assistance Publique Hopitaux de Paris. He is Professor of Neurosurgery at Paris 6 Sorbonne University School of Medicine in Paris, France, and performs research on laser and ultrasound technologies for MRI guided minimally invasive surgical procedures and Blood-Brain Barrier opening. He is head of the Advanced Surgical Technologies Research University Lab and founded CarThera, a university spin-off company, in 2010.
Howard Eisenberg, MD
Dr. Eisenberg is a board certified neurosurgeon with special interests in brain tumors, skull based surgery, acoustic neuroma, epilepsy and movement disorders. He is currently the R.K. Thompson Professor and Chairman, Department of Neurosurgery, University of Maryland School of Medicine and Medical Systems, Baltimore, as well as a professor in the Department of Pharmacology and Experimental Therapeutics.
Katherine Ferrara, PhD
Dr. Ferrara is a Distinguished Professor of Biomedical Engineering at UC Davis and the Director of the Center for Content Rich Evaluation of Therapeutic Efficacy (cCRETE). She is a member of the National Academy of Engineering and a fellow of the IEEE, American Association for the Advancement of Science, the Biomedical Engineering Society, the Acoustical Society of America and the American Institute of Medical and Biological Engineering. Her laboratory is known for early work in aspects of ultrasonics and has more recently expanded their focus to broadly investigate molecular imaging and drug delivery.
Joseph Frank, MD, MS
Dr. Frank is a tenured scientist at NIH whose research focus is directed towards improving cellular therapies for regenerative medicine and malignancy. His current interest is in investigating the ability of pulsed focused ultrasound to enhance cell homing and the mechanotransductive effects of ultrasound in tissues and diseases.
Wladyslaw (Wady) Gedroyc, MD
Dr. Gedroyc was born and educated in London. His radiology training was at Guy's Hospital London followed by one year at Penn State University at Hershey Medical Center. For the past 19 years, he has been a radiology consultant at St. Mary's Hospital and medical director of the MR unit during that time. Today, he is the Personal Chair at Imperial College London and is a Consultant Radiologist for Imperial College Healthcare NHS Trust. He has over 80 papers published in peer reviewed journals, mostly on MR related topics. These include multiple research papers on interventional MRI and the development of MRgFUS in various clinical situations. He is an international expert on MR-guided interventional techniques. The widespread use of MR-guided focused ultrasound treatment for fibroids has directly evolved from his initial research work in this area. He has multiple projects currently underway investigating the use of MR-guided focused ultrasound in the treatment of liver tumors, bone secondary tumors, back pain, prostate cancer, and fertility.
Michael Gertner, MD
Dr. Gertner is the CEO of Kona Medical, as well as the inventor of the technology and founder of the company. Kona is developing non-invasive nerve ablation therapies for hypertension and other disorders. Dr. Gertner is a surgeon by training, having practiced trauma and emergency surgery for 10 years. He is also the primary author on over 100 patents.
Pejman Ghanouni, MD, PhD
Dr. Ghanouni is an Assistant Professor in the Body MRI section of the Department of Radiology at Stanford University, where he treats uterine fibroids, painful osseous metastases, essential tremor, prostate cancer, and soft tissue tumors of the extremities. He is also actively involved in preclinical research on cancer biomarker detection, FUS hardware and MR sequence development for improved brain targeting, and improved brain and body thermometry.
Chandan Guha, MBBS, PhD
Dr. Guha is the Vice Chair of Radiation Oncology at the Albert Einstein College of Medicine (Einstein) and Montefiore Medical Center and Professor of Pathology, Urology, and Radiation Oncology at Einstein. He is also the founding director of Einstein's Institute for Onco-physics. Dr. Guha's research work is in the fields of immunology, radiation oncology, and liver diseases, and has been focused on two areas: immunotherapeutic approaches for cancer therapy, and the use of regenerative strategies to repopulate injured tissue by use of stem cell-based technologies. As a clinician, he is also involved in treating prostate and liver cancers and is an investigator in several worldwide clinical trials.
Joo Ha Hwang, MD, PhD
Dr. Hwang is an Associate Professor in the Department of Medicine in the Division of Gastroenterology at the University of Washington with adjunct appointments in the Departments of Radiology and Bioengineering. He is the chief of the Gastroenterology Section at Harborview Medical Center. His clinical practice is in Gastroenterology with a focus on performing endoscopic ultrasound (EUS) for diagnosing and staging pancreatic cancer. In addition, he has a PhD in Bioengineering and maintains an active lab performing high-intensity focused ultrasound (HIFU) research. Current research activities in his lab include ultrasound-enhanced drug delivery, ultrasound-mediated vascular bioefffects, and optimization of HIFU ablation.
Kullervo Hynynen, MSc, PhD
Dr. Hynynen is a Professor in the Department of Medical Biophysics and Institute of Biomaterials & Biomedical Engineering (IBBME) at the University of Toronto and a Senior Scientist and director of Imaging Research at Sunnybrook Research Institute, and the appointed Canada Research Chair in Imaging Systems and Image-Guided Therapy (Tier 1). He also directs the Centre for Research in Image-guided therapeutics at Sunnybrook. He received his BSc and MSc in Physics from the University of Kuopio in Finland and his PhD in Biomedical Physics and Biomedical Engineering from the University of Aberdeen, UK. Most of his current research interests are centered in utilizing focused ultrasound in medicine.
AeRang Kim, MD, PhD
Dr. Kim's research focuses on the development of novel therapeutics for pediatric cancer. She serves as the principal investigator of multiple phase I/II trials in pediatric oncology/sarcomas/NF1 and the Children's National phase 1 principal investigator for the Children's Oncology Group Developmental Therapeutics Consortium. She is the principal investigator of the clinical trial of MR-HIFU ablation in pediatric solid tumors. She is an assistant professor of pediatrics and solid tumors faculty member at Children's National Medical Center specializing in sarcomas and developmental therapeutics.
Young-sun Kim, MD
Dr. Kim is a radiologist and an associate professor of department of Radiology of Samsung Medical Center, Sungkyunkwan University School of Medicine in Seoul, Korea. He performs clinical MR-HIFU ablation therapy for the treatment of uterine fibroids and preclinical translational research of HIFU application to cancer treatment.
Cyril Lafon, PhD
Dr. Lafon is a research director at INSERM. His early research included developing interstitial HIFU probes and ultrasound-induced hemostasis and the development of tissue mimicking phantoms for HIFU applications. His recent research interests focus on modeling ultrasound wave propagation, development of ultrasonic therapeutic devices for thermal ablation or drug delivery.
Chrit Moonen, PhD
Dr. Moonen is currently professor at the Division of Imaging at the University Medical Center in Utrecht, the Netherlands. His recent work is in MRI-guided focused ultrasound, image-guided drug delivery, and molecular and cellular imaging. He received the European Magnetic Resonance Award 2000, is a Fellow of the International Society of Magnetic Resonance in Medicine, of the European Society of Magnetic Resonance in Medicine and Biology, and of the World Molecular Imaging Society.
Alessandro Napoli, MD
Dr. Napoli is a professor of radiology in the Department of Radiological, Oncology and Pathological Science at the Sapienza University of Rome where he is also head of the MR-Guided Focused Ultrasound Treatment Unit. He is very active in the field, serving as president elect of the European Society of Focused Ultrasound Therapy as well as organizing the first two European symposia on focused ultrasound.
Jaron Rabinovici, MD
Dr. Rabinovici is Head of Department of Obstetrics and Gynecology at the Sheba Medical Center, Israel. The team at the Sheba Medical Center has been involved both in clinical and academic aspects of MRgFUS treatments of uterine fibroids and adenomyosis since the early days.
Naren Sanghvi, PhD
Dr. Sanghvi is the co-founder of Focus Surgery Inc. and a pioneer in the field of high intensity focused ultrasound (HIFU) technology. He is the inventor and developer of the Sonablate® HIFU device for the treatment of prostate disease. He served at the Indiana University School of Medicine as an associate professor and senior research scientist in the Department of Physiology and Biophysics where pioneering work for the development of echocardiography, breast ultrasound imaging and prostate treatment with ultrasound was performed. Sanghvi worked with Prof. F. J. Fry and developed the first clinical HIFU ultrasound image guided device for the treatment of brain cancer in 1972 that was used for the treatment of Glioblastoma. He served as a Chief visiting scientist at Hitachi Central Research Laboratories, Tokyo, Japan from 1989-1990. Sanghvi holds 23 patents in systems, transducer design and process and has several pending patents. Sanghvi is a member and fellow in the American Institute of Ultrasound in Medicine, the Acoustical Society of America and the International Society of Therapeutic Ultrasound.
Gail ter Haar, PhD
Dr. ter Haar is a Professor in Physics in the Division of Radiotherapy and Imaging at the Institute for Cancer Research in London. She leads a team researching focused ultrasound on many fronts, designing a clinical prototype device, developing methods of measuring and calibrating HIFU treatments, and studying the biology and biophysics involved in the treatments. Dr. ter Haar is currently chair of both the British and European committees for medical ultrasound safety and scientific secretary of the European Society for Hyperthermic Oncology. She holds an MA(Oxon) and PhD in Physics and has been awarded a DSc(Oxon) in clinical medicine.
Joan Vidal-Jove, MD, PhD
Dr. Vidal-Jove is the Head of Surgical Oncology at Barcelona University Hospital and is currently studying focused ultrasound for pancreatic cancer. His early research indicates that FUS with chemotherapy may have the ability to extend survival of patients with unresectable tumors.
Charles Viviano, MD, PhD
Dr. Viviano is a urologist and medical officer in the Urology and Lithotripsy Devices Branch in the Center for Devices and Radiological Health at the Food and Drug Administration. He was involved in the final FDA clinical review of the currently available, legally marketed prostate HIFU devices. He has represented the FDA at the American Urological Association's 2016 Annual Meeting Plenary session, "HIFU - Hope or Hype: The FDA Path to Approval". Prior to joining the FDA, he was an Assistant Professor at Duke University where his practice focused on General Urology and Men's Health. Before joining the faculty at Duke, he was in private practice in New London, Connecticut. He received his medical education at the University of Connecticut, where he also performed his residency in Urology. He received his PhD in Toxicology from the University of North Carolina at Chapel Hill.
Bradford Wood, MD
Dr. Wood is Director of the NIH Center for Interventional Oncology, Chief of Interventional Radiology, and a Senior Investigator with Tenure at NIH. He earned both his undergraduate and graduate degrees from The University of Virginia, then completed an Internship in Internal Medicine, followed by Residency in Diagnostic Radiology at Georgetown University, where he was Chief Resident. He then went on to do double fellowships at Massachusetts General Hospital at Harvard in Abdominal Imaging and Intervention and Vascular & Interventional Radiology, and stayed on staff at Massachusetts General Hospital / Harvard after training, and is board-certified in Vascular and Interventional Radiology as well as Diagnostic Radiology.